Eric Prinssen

Fenobam: A Clinically Validated Nonbenzodiazepine Anxiolytic Is a Potent, Selective, and Noncompetitive mGlu5 Receptor Antagonist with Inverse Agonist Activity

Richard H. Porter, Georg Jaeschke, Will Spooren et al. · Journal of Pharmacology and Experimental Therapeutics · 2005 · 314 citations · Full text

Medicine, Medicinal Chemistry, Pharmacology +15

A combined marble burying–locomotor activity test in mice: A practical screening test with sensitivity to different classes of anxiolytics and antidepressants

Laurent B. Nicolas, Yeter Kolb, Eric Prinssen · European Journal of Pharmacology · 2006 · 228 citations

Medicine, Behavioral Sciences, Pharmacology +16

Zebrafish behavioral profiling identifies multitarget antipsychotic-like compounds

Giancarlo N. Bruni, Andrew J. Rennekamp, Andrea Velenich et al. · Nature Chemical Biology · 2016 · 164 citations · Full text

Medicine, Neuroscience, Pharmacology +11

RO4938581, a novel cognitive enhancer acting at GABAA α5 subunit-containing receptors

Theresa M. Ballard, Frédéric Knoflach, Eric Prinssen et al. · Psychopharmacology · 2008 · 155 citations

Medicine, Molecular Genetics, Neuroscience +13

CTEP: A Novel, Potent, Long-Acting, and Orally Bioavailable Metabotropic Glutamate Receptor 5 Inhibitor

Lothar Lindemann, Georg Jaeschke, Aubin Michalon et al. · Journal of Pharmacology and Experimental Therapeutics · 2011 · 121 citations

Medicine, Neuroscience, Pharmacology +14